TG Therapeutics Inc (TGTX)

Current ratio

Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020
Total current assets US$ in thousands 566,359 574,069 389,150 360,581 317,943 319,114 208,574 184,783 168,274 182,922 202,560 242,216 330,965 371,779 455,068 535,013 611,740 260,335 280,938 88,016
Total current liabilities US$ in thousands 90,679 125,114 108,664 99,684 53,720 57,678 72,667 63,076 53,201 36,447 43,326 54,656 65,384 87,655 87,551 92,494 87,554 77,670 67,537 63,118
Current ratio 6.25 4.59 3.58 3.62 5.92 5.53 2.87 2.93 3.16 5.02 4.68 4.43 5.06 4.24 5.20 5.78 6.99 3.35 4.16 1.39

December 31, 2024 calculation

Current ratio = Total current assets ÷ Total current liabilities
= $566,359K ÷ $90,679K
= 6.25

TG Therapeutics Inc's current ratio has fluctuated over the past few years, indicating changes in its short-term liquidity position.

As of December 31, 2024, the company's current ratio stands at 6.25, suggesting that it has $6.25 in current assets for every $1 in current liabilities, which reflects a strong liquidity position.

Looking at the trend, the ratio peaked at 6.99 on December 31, 2020, and has generally remained above 4 since then, with some fluctuations. However, in recent quarters, the current ratio has started to decline, reaching 3.58 on June 30, 2024.

While the current ratio is an important measure of a company's short-term financial health, it is essential to consider other financial ratios and factors to get a comprehensive understanding of TG Therapeutics Inc's overall financial performance and liquidity management.